Copyright
©The Author(s) 2019.
World J Gastrointest Oncol. Feb 15, 2019; 11(2): 139-152
Published online Feb 15, 2019. doi: 10.4251/wjgo.v11.i2.139
Published online Feb 15, 2019. doi: 10.4251/wjgo.v11.i2.139
Table 5 Survival difference between pancreatic and stomach neuroendocrine tumors
| Tumor location, n = 54 | 5-yr survival | P value | ||
| Yes, n = 35 | No, n = 19 | |||
| Stomach | 53.7% | 65.7% | 31.5% | 0.016 |
| Pancreas | 46.3% | 34.3% | 68.5% | |
- Citation: Komaç Ö, Bengi G, Sağol Ö, Akarsu M. C-reactive protein may be a prognostic factor for the whole gastroenteropancreatic neuroendocrine tumor group. World J Gastrointest Oncol 2019; 11(2): 139-152
- URL: https://www.wjgnet.com/1948-5204/full/v11/i2/139.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v11.i2.139